| European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other … I Graham, D Atar, K Borch-Johnsen, G Boysen, G Burell, R Cifkova, ... European heart journal 28 (19), 2375-2414, 2007 | 4052 | 2007 |
| Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance … E Bonora, G Targher, M Alberiche, RC Bonadonna, F Saggiani, ... Diabetes care 23 (1), 57-63, 2000 | 3067 | 2000 |
| Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease G Targher, CP Day, E Bonora New England Journal of Medicine 363 (14), 1341-1350, 2010 | 2322 | 2010 |
| Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes A Zampetaki, S Kiechl, I Drozdov, P Willeit, U Mayr, M Prokopi, A Mayr, ... Circulation research 107 (6), 810-817, 2010 | 1692 | 2010 |
| Cardiorenal end points in a trial of aliskiren for type 2 diabetes HH Parving, BM Brenner, JJV McMurray, D De Zeeuw, SM Haffner, ... New England Journal of Medicine 367 (23), 2204-2213, 2012 | 1625 | 2012 |
| Toll-like receptor 4 polymorphisms and atherogenesis S Kiechl, E Lorenz, M Reindl, CJ Wiedermann, F Oberhollenzer, E Bonora, ... New England Journal of Medicine 347 (3), 185-192, 2002 | 1421 | 2002 |
| Prevalence of insulin resistance in metabolic disorders: the Bruneck Study. E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, G Targher, ... Diabetes 47 (10), 1643-1649, 1998 | 1372 | 1998 |
| Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance I Zavaroni, E Bonora, M Pagliara, E Dall'Aglio, L Luchetti, G Buonanno, ... New England Journal of Medicine 320 (11), 702-706, 1989 | 1150 | 1989 |
| HOMA-estimated insulin resistance is an independent predictor of cardiovascular disease in type 2 diabetic subjects: prospective data from the Verona Diabetes Complications Study E Bonora, G Formentini, F Calcaterra, S Lombardi, F Marini, L Zenari, ... Diabetes care 25 (7), 1135-1141, 2002 | 762 | 2002 |
| Chronic infections and the risk of carotid atherosclerosis: prospective results from a large population study S Kiechl, G Egger, M Mayr, CJ Wiedermann, E Bonora, F Oberhollenzer, ... Circulation 103 (8), 1064-1070, 2001 | 734 | 2001 |
| Estimates of In Vivo Insulin Action in Man: Comparison of Insulin Tolerance Tests with Euglycemic and Hyperglycemic Glucose Clamp Studies E Bonora, P Moghetti, C Zancanaro, M Cigolini, M QUERENA, ... The Journal of Clinical Endocrinology & Metabolism 68 (2), 374-378, 1989 | 696 | 1989 |
| Insulin causes endothelial dysfunction in humans: sites and mechanisms G Arcaro, A Cretti, S Balzano, A Lechi, M Muggeo, E Bonora, ... Circulation 105 (5), 576-582, 2002 | 636 | 2002 |
| Postprandial blood glucose as a risk factor for cardiovascular disease in type II diabetes: the epidemiological evidence E Bonora, M Muggeo Diabetologia 44, 2107-2114, 2001 | 590 | 2001 |
| Identification of FOXP2 truncation as a novel cause of developmental speech and language deficits KD MacDermot, E Bonora, N Sykes, AM Coupe, CSL Lai, SC Vernes, ... The American Journal of Human Genetics 76 (6), 1074-1080, 2005 | 571 | 2005 |
| Cause-specific mortality in type 2 diabetes. The Verona Diabetes Study. R De Marco, F Locatelli, G Zoppini, G Verlato, E Bonora, M Muggeo Diabetes care 22 (5), 756-761, 1999 | 561 | 1999 |
| Nonalcoholic fatty liver disease and risk of incident type 2 diabetes: a meta-analysis A Mantovani, CD Byrne, E Bonora, G Targher Diabetes care 41 (2), 372-382, 2018 | 536 | 2018 |
| Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study E Bonora, S Kiechl, J Willeit, F Oberhollenzer, G Egger, RC Bonadonna, ... Diabetes care 26 (4), 1251-1257, 2003 | 493 | 2003 |
| The pros and cons of diagnosing diabetes with A1C E Bonora, J Tuomilehto Diabetes care 34 (Suppl 2), S184, 2011 | 480 | 2011 |
| Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment G Danaei, Y Lu, GM Singh, E Carnahan, GA Stevens, MJ Cowan, ... Lancet Diabetes & Endocrinology, 2014 | 442 | 2014 |
| Fasting plasma glucose variability predicts 10-year survival of type 2 diabetic patients: the Verona Diabetes Study. M Muggeo, G Zoppini, E Bonora, E Brun, RC Bonadonna, P Moghetti, ... Diabetes care 23 (1), 45-50, 2000 | 439 | 2000 |
